Stock 300318 BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Equities

300318

CNE000001QR4

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
4.78 CNY 0.00% Intraday chart for Beijing Bohui Innovation Biotechnology Group Co., Ltd. +1.70% -23.40%
Apr. 26 Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Bohui Innovation Biotechnology Secures Blood Collection License in China’s Yunnan Province
MT
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Announces Board and Executive Changes
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Bohui Innovation Biotech Unit Gets Operation Permit for Plasma Center
MT
Beijing Bohui Innovation Biotech Unit Sells Land for 108.2 Million Yuan
MT
Bohui Innovation Biotechnology Unit to Sell Land-Use Rights For 108 Million Yuan; Shares Fall Nearly 4%
MT
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) dropped from S&P Global BMI Index
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index
CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. cancelled the transaction announced on February 17, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300318 Stock
  4. News Beijing Bohui Innovation Biotechnology Group Co., Ltd.